MedPath

Effect of propofol-ketamin and propofol-fentanyl in colonoscopy

Phase 2
Conditions
disease of intestine,unspecified.
disease of intestine,unspecified
k63.9
Registration Number
IRCT20190529043750N1
Lead Sponsor
Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
200
Inclusion Criteria

patients scheduled for comlete elective colonoscopy
18-55 years old
ASA class I-II

Exclusion Criteria

History of large bowel surgery
Pregnancy
Patients with psychiatric and emotional disorder
History of addiction
History of allergic reaction
History of pulmonary and metabolic disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before of discharge. Method of measurement: Visual Analogues Scale.
Secondary Outcome Measures
NameTimeMethod
Drug adverse effects. Timepoint: Before and after colonoscopy. Method of measurement: Before and after colonoscopy.;Colonoscopist satisfaction. Timepoint: After colonoscopy. Method of measurement: Numerical rating scale for colonoscopist satisfaction.;Blood pressure. Timepoint: Every 5 minutes. Method of measurement: Noninvasive cuff measurrment.;Heart rate. Timepoint: Every 5 minutes. Method of measurement: Pulse counting.
© Copyright 2025. All Rights Reserved by MedPath